Total submissions: 25
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000172618 | SCV000051286 | likely benign | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000040808 | SCV000064499 | benign | not specified | 2015-02-19 | criteria provided, single submitter | clinical testing | p.Arg28781His in exon 288 of TTN: This variant is not expected to have clinical significance because it has been identified in 1.5% (98/6608) of Finnish chromos omes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs181104321). |
Gene |
RCV000172618 | SCV000237783 | likely benign | not provided | 2020-10-09 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 23861362, 23396983) |
Invitae | RCV001081587 | SCV000286921 | benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000172618 | SCV001146539 | benign | not provided | 2019-06-17 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001129392 | SCV001288915 | benign | Tibial muscular dystrophy | 2017-10-24 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV001129393 | SCV001288916 | likely benign | Early-onset myopathy with fatal cardiomyopathy | 2017-10-24 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV001129394 | SCV001288917 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2017-10-24 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV001136388 | SCV001296223 | benign | Dilated cardiomyopathy 1G | 2017-10-24 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV001136389 | SCV001296224 | likely benign | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-10-24 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
CHEO Genetics Diagnostic Laboratory, |
RCV001171241 | SCV001333945 | benign | Cardiomyopathy | 2018-01-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001136389 | SCV002102147 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001129394 | SCV002102148 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001129393 | SCV002102149 | benign | Early-onset myopathy with fatal cardiomyopathy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001129392 | SCV002102152 | benign | Tibial muscular dystrophy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000172618 | SCV002496570 | likely benign | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | TTN: BS2 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000040808 | SCV002500359 | likely benign | not specified | 2022-03-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002362651 | SCV002663339 | benign | Cardiovascular phenotype | 2018-03-15 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV000172618 | SCV003800141 | likely benign | not provided | 2022-09-20 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004534940 | SCV004721433 | benign | TTN-related disorder | 2022-03-21 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Diagnostic Laboratory, |
RCV000172618 | SCV001740296 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000040808 | SCV001919662 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000172618 | SCV001927607 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000172618 | SCV001955336 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000040808 | SCV001963980 | benign | not specified | no assertion criteria provided | clinical testing |